1.
Laughrea P-A, Hébert M. Staying ahead of dupilumab-associated ocular surface disease. Can Dermatol Today [Internet]. 2022 Sep. 1 [cited 2024 Oct. 30];3(3):26–34. Available from: https://canadiandermatologytoday.com/article/view/3-3-laughrea-hebert